These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
335 related items for PubMed ID: 22126778
1. [Cardiovascular risk profile in systemic lupus erythematosus: a cross-sectional study of 879 patients]. He CS, Shi W, Ye ZM, Liang XL, Zhang B, Liu SX. Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1910-3. PubMed ID: 22126778 [Abstract] [Full Text] [Related]
3. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study. Bessant R, Duncan R, Ambler G, Swanton J, Isenberg DA, Gordon C, Rahman A. Arthritis Rheum; 2006 Dec 15; 55(6):892-9. PubMed ID: 17139666 [Abstract] [Full Text] [Related]
4. Alterations in circulating fatty acid composition in patients with systemic lupus erythematosus: a pilot study. Aghdassi E, Ma DW, Morrison S, Hillyer LM, Clarke S, Gladman DD, Urowitz MB, Fortin PR. JPEN J Parenter Enteral Nutr; 2011 Mar 15; 35(2):198-208. PubMed ID: 21378249 [Abstract] [Full Text] [Related]
5. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients. Zhang CY, Lu LJ, Li FH, Li HL, Gu YY, Chen SL, Bao CD. J Clin Rheumatol; 2009 Apr 15; 15(3):111-6. PubMed ID: 19300290 [Abstract] [Full Text] [Related]
7. Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic lupus erythematosus patients. Bahrehmand F, Vaisi-Raygani A, Kiani A, Rahimi Z, Tavilani H, Navabi SJ, Shakiba E, Hassanzadeh N, Pourmotabbed T. Lupus; 2012 May 15; 21(6):616-24. PubMed ID: 22323339 [Abstract] [Full Text] [Related]
10. Peripheral vascular disease in systemic lupus patients. June RR, Scalzi LV. J Clin Rheumatol; 2013 Oct 15; 19(7):367-72. PubMed ID: 24048099 [Abstract] [Full Text] [Related]
11. Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus. O'Neill SG, Giles I, Lambrianides A, Manson J, D'Cruz D, Schrieber L, March LM, Latchman DS, Isenberg DA, Rahman A. Arthritis Rheum; 2010 Mar 15; 62(3):845-54. PubMed ID: 20131231 [Abstract] [Full Text] [Related]
13. Invasive fungal infection in patients with systemic lupus erythematosus: experience from a single institute of Northern China. Fan YC, Li WG, Zheng MH, Gao W, Zhang YY, Song LJ. Gene; 2012 Sep 10; 506(1):184-7. PubMed ID: 22750799 [Abstract] [Full Text] [Related]
15. Gender differences are associated with the clinical features of systemic lupus erythematosus. Ding Y, He J, Guo JP, Dai YJ, Li C, Feng M, Li R, Li ZG. Chin Med J (Engl); 2012 Jul 10; 125(14):2477-81. PubMed ID: 22882925 [Abstract] [Full Text] [Related]
16. [Clinico-biological issues of systemic lupus erythematosus patients]. Belibou IC, Ancuţa C, Miu S, Ancuţa E, Păstrăguş C, Chirieac R. Rev Med Chir Soc Med Nat Iasi; 2012 Jul 10; 116(1):83-9. PubMed ID: 23077877 [Abstract] [Full Text] [Related]
19. Prevalence and associated factors of resting electrocardiogram abnormalities among systemic lupus erythematosus patients without cardiovascular disease. Al Rayes H, Harvey PJ, Gladman DD, Su J, Sabapathy A, Urowitz MB, Touma Z. Arthritis Res Ther; 2017 Feb 10; 19(1):31. PubMed ID: 28183339 [Abstract] [Full Text] [Related]
20. Dyslipidemia in pediatric systemic lupus erythematosus: the relationship with disease activity and plasma homocysteine and cysteine concentrations. Ortiz TT, Terreri MT, Caetano M, Souza FS, D'Almeida V, Sarni RO, Hilário MO. Ann Nutr Metab; 2013 Feb 10; 63(1-2):77-82. PubMed ID: 23942034 [Abstract] [Full Text] [Related] Page: [Next] [New Search]